EG00229

EG00229 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:EG00229
CAS:1210945-69-9
Purity:98.00% Package:10 mg;100 mg;2 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:EG00229 TFA
CAS:1210945-69-9
Purity:98% Package:5mg Remarks:V33581
Company Name: Nantong HI-FUTURE Biology Co., Ltd.
Tel: +undefined18051384581
Email: sales@chemhifuture.com
Products Intro: Product Name:EG00229
CAS:1210945-69-9
Purity:0.98 Package:5mg,10mg,100mg,500mg,1g,5g,10g,more
Company Name: Wuhan Topule Biopharmaceutical Co., Ltd
Tel: +8618327326525
Email: masar@topule.com
Products Intro: Product Name:EG00229
CAS:1210945-69-9
Purity:97% Package:100mg;1g;500g Remarks:Topule Company operates with integrity and has its own laboratory, which supports packaging and customization. Payment will be made after the product has passed third-party testing
Company Name: Shanghai Acmec Biochemical Technology Co., Ltd.
Tel: +undefined18621343501
Email: product@acmec-e.com
Products Intro: Product Name:EG00229
CAS:1210945-69-9
Purity:98% Package:100mg, 10mg, 50mg, 5mg
EG00229 Basic information
Product Name:EG00229
Synonyms:EG00229;EG00229 TFA;EG 00229 Trifluoroacetate;CS-1273;EG00229,EG-00229;EG 00229 (trifluoroacetate salt)
CAS:1210945-69-9
MF:C19H20F3N7O7S3
MW:611.59
EINECS:
Product Categories:
Mol File:1210945-69-9.mol
EG00229 Structure
EG00229 Chemical Properties
storage temp. Store at -20°C
solubility Soluble in DMSO
form Powder
color Light yellow to yellow
Safety Information
MSDS Information
EG00229 Usage And Synthesis
UsesEG 00229 Trifluoroacetic Acid Salt is an antagonist of the VEGFA receptor neuropilin (NRP1). This antagonism can result in the attenuation of prostate carcinoma cell proliferation.
Biological Activityeg00229 is a small molecule inhibitor of neuropilin-1(nrp1) with an ic50 of 3μm [1].eg00229 has been reported to inhibit vegf-a binding to pae/nrp1 in the nrp1and bt-vegf-a binding to purified nrp1 b1 domain in a cell-free assay with an ic50 value of 8μm and 3μm, respectively. in addition, eg00229 has also shown the inhibition of vegf-a binding to vegfr2, vegfr1 and nrp1 in human umbilical vein endothelial cells (huvecs) in a dose-dependent manner with an ic50 value of 23μm [1]. besides, eg00229 has been revealed to prevent tuftsin binding to the nrp1 which is at the cell surface. moreover, eg00229 has been noted to suppress the anti-inflammatory m2 shift in microglia induced by tuftsin and thus potently prevent tuftsin’s action [2].
storageStore at -20°C
references[1] jarvis a1, allerston ck, jia h, herzog b, garza-garcia a, winfield n, ellard k, aqil r, lynch r, chapman c, hartzoulakis b, nally j, stewart m, cheng l, menon m, tickner m, djordjevic s, driscoll pc, zachary i, selwood dl.small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor a (vegf-a) interaction. j med chem. 2010 mar 11;53(5):2215-26.
[2] nissen jc1, selwood dl, tsirka se. tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway. j neurochem. 2013 nov;127(3):394-402.
EG00229 Preparation Products And Raw materials
Tag:EG00229(1210945-69-9) Related Product Information